J.J. Gout-Zwart, BSc

E-mail:
j.j.gout-zwart med.umcg.nl

Research

Publications
  1. Budget Impact Analysis of Metformin Sustained Release for the Treatment of Type 2 Diabetes in The Netherlands

    Gout-Zwart, J. J., de Jong, L. A., Saptenno, L. & Postma, M. J., 18-Sep-2019, In : PharmacoEconomics - open. 10 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  2. Costs of clinical events in type 2 diabetes mellitus patients in the Netherlands: A systematic review

    van Schoonhoven, A. V., Gout-Zwart, J. J., de Vries, M. J. S., van Asselt, A. D. I., Dvortsin, E., Vemer, P., van Boven, J. F. M. & Postma, M. J., 1-Sep-2019, In : PLoS ONE. 14, 9, 22 p., e0221856.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. Rivaroxaban for non-valvular atrial fibrillation and venous thromboembolism in the Netherlands: a real-world data based cost-effectiveness analysis

    de Jong, L. A., Gout-Zwart, J. J., van den Bosch, M., Koops, M. & Postma, M. J., 3-Apr-2019, In : Journal of Medical Economics. 22, 4, p. 306-318 13 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  4. Extended Treatment with Apixaban for Venous Thromboembolism Prevention in the Netherlands: Clinical and Economic Effects

    De Jong, L. A., Gout-Zwart, J. J., Stevanovic, J., Rila, H., Koops, M., Huisman, M. V. & Postma, M. J., 30-Dec-2018, In : BMJ Open. 2, 3, p. e315-e324 10 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  5. Trends in direct oral anticoagulant (DOAC) use: Health benefits and patient preference

    de Jong, L. A., Koops, M., Gout-Zwart, J. J., Beinema, M. J., Hemels, M. E. W., Postma, M. J. & Brouwers, J. R. B. J., 1-Dec-2018, In : Netherlands Journal of Medicine. 76, 10, p. 426-430 5 p.

    Research output: Contribution to journalReview articleAcademicpeer-review

View all (11) »

View graph of relations

ID: 38980907